AJICAP Second Generation: Improved Chemical Site-Specific Conjugation Technology for Antibody–Drug Conjugate ProductionTomohiro Fujii, Kei Yamada, Akira Nakayama et al.|Bioconjugate Chemistry|2023Cited by 62
Chemical Site-Specific Conjugation Platform to Improve the Pharmacokinetics and Therapeutic Index of Antibody–Drug ConjugatesYutaka Matsuda, Tatsuya Okuzumi, Takuya Seki et al.|Molecular Pharmaceutics|2021Cited by 61
Chromatographic analysis of site-specific antibody-drug conjugates produced by AJICAP first-generation technology using a recombinant FcγIIIa receptor-ligand affinity columnYutaka Matsuda, Brian A. Mendelsohn, Atis Chakrabarti et al.|Journal of Chromatography B|2021Cited by 29
AJICAP-M: Traceless Affinity Peptide Mediated Conjugation Technology for Site-Selective Antibody–Drug Conjugate SynthesisYutaka Matsuda, Shigeo Hirasawa, Natsuki Shikida et al.|Organic Letters|2024Cited by 28
AJICAP Second Generation: Improved Chemical Site-Specific Conjugation Technology for Antibody-Drug Conjugate ProductionTomohiro Fujii, Kei Yamada, Yutaka Matsuda et al.|ChemRxiv|2023Cited by 20